cas 1535338-19-2|| where to buy 5H,6H,8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-ylmethanamine

Nom du produit:5H,6H,8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-ylmethanamine

IUPAC Name:1-{5H,6H,8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-yl}methanamine

Unité d'emballage	Stock disponible	Prix($)
CM433779-100mg	3-4 Weeks	ƈǙƈ
CM433779-250mg	3-4 Weeks	ǙƈŮ
CM433779-500mg	4-5 Weeks	ľĲƿ
CM433779-1g	4-5 Weeks	Ĳľƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1535338-19-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1535338-19-2; Formule moléculaire:C6H10N4O; Point de fusion:-; Code SMILES:NCC1=NN=C2COCCN12; Densité:

: Numéro de catalogue:CM433779; Poids moléculaire:154.17; Point d'ébullition:; N° Mdl:MFCD26673153; Stockage:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.